| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |